Future costs in cost-effectiveness analysis: An empirical assessment

European Journal of Health Economics

Volumn 13, Issue 1, 2012, Pages 63-70

  Kruse, Marie ^a   Sørensen, Jan ^a   Gyrd Hansen, Dorte ^b  

^a UNIVERSITY OF SOUTHERN DENMARK   (Denmark)

^b Dansk Sundhedsinstitut   (Denmark)

Author keywords

Cost effectiveness analysis; Future costs; Life years saved

Indexed keywords

ARTICLE; COST EFFECTIVENESS ANALYSIS; HEALTH CARE; HEALTH CARE COST; HEALTH PROMOTION; HEALTH SERVICE; HOUSEHOLD; HUMAN; PRESCRIPTION; PRIORITY JOURNAL; SURVIVAL;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CHILD; CHILD, PRESCHOOL; COST-BENEFIT ANALYSIS; DELIVERY OF HEALTH CARE; DENMARK; FORECASTING; HEALTH PROMOTION; HEALTH SERVICES; HUMANS; LIFE EXPECTANCY; MIDDLE AGED; REGISTRIES; YOUNG ADULT;

EID: 84858705387     PISSN: 16187598     EISSN: 16187601     Source Type: Journal    
DOI: 10.1007/s10198-010-0280-0     Document Type: Article

References (23)

1. Luce, B.R., Manning Jr, W.G., Siegel, J.E., Lipscomb, J.: Estimating costs in cost-effectiveness analysis. In: Gold, M.R., Siegel, J.B., Russell, L.B., Weinstein, M.C. (eds.) Cost-effectiveness in health and medicine, pp. 176-213. Oxford University Press, New York (1996)
2. Meltzer, D.: Accounting for future costs in medical cost-effectiveness analysis. J. Health Econ. 16(1), 33-64 (1997)
3. Garber, A.M., Phelps, C.E.: Economic foundations of cost-effectiveness analysis. J. Health Econ. 16(1), 1-31 (1997)
4. Bleichrodt, H., Quiggin, J.: Life-cycle preferences over consumption and health: When is cost-effectiveness analysis equivalent to cost-benefit analysis? J. Health Econ. 18(6), 681-708 (1999)
5. Nyman, J.A.: Should the consumption of survivors be included as a cost in cost-utility analysis? Health Econ. 13(5), 417-427 (2004)
6. Garber, A.M., Phelps, C.E.: Future costs and the future of costeff-ectiveness analysis. J. Health Econ. 27(4), 819-821 (2008)
7. Meltzer, D.: Response to "Future costs and the future of cost-effectiveness analysis". J. Health Econ. 27(4), 822-825 (2008)
8. Lundin, D., Ramsberg, J.: On survival consumption costs: A reply to Nyman. Health Econ. 17(2), 293-297 (2008)
9. Gandjour, A.: Consumption costs and earnings during added years of life-a reply to Nyman. Health Econ. 15(3), 315-317 (2006)
10. Gandjour, A.: Survivor costs in cost-effectiveness analysis. Ann. Intern. Med. 144(7), 534-535 (2006)
11. Gold, M.R., Siegel, J.E., Russell, L.B., Weinstein, M.C.: Cost-effectiveness in Health and Medicine. Oxford University Press, New York (1996)
12. Blomqvist, A.: QALYs, standard gambles, and the expected budget constraint. J. Health Econ. 21(2), 181-195 (2002)
13. Meltzer, D., Egleston, B., Stoffel, D., Dasbach, E.: Effect of future costs on cost-effectiveness of medical interventions among young adults: The example of intensive therapy for type 1 diabetes mellitus. Med. Care 38(6), 679-685 (2000)
14. Manns, B., Meltzer, D., Taub, K., Donaldson, C.: Illustrating the impact of including future costs in economic evaluations: An application to end-stage renal disease care. Health Econ. 12(11), 949-958 (2003)
15. Ekman, M.: Studies in Health Economics-Modelling and Data Analysis of Costs and Survival [Stockholm School of Economics]. (2002)
16. Præstholm, S., Christensen, L., Jørgensen, S.A: [Pensions savings]. (2009), Online source
17. Attanasio, O.P.: Cohort analysis of saving behavior by US households. J. Hum. Resour. 33(3), 575-609 (1998)
18. The Danish Ministry of Health: Hospital Funding and Casemix. 1-89. Copenhagen (1999) Report
19. Tengs, T.O., Adams, M.E., Pliskin, J.S., Safran, D.G., Siegel, J.E., Weinstein, M.C., et al.: Five-hundred life-saving interventions and their cost-effectiveness. Risk Anal. 15(3), 369-390 (1995)
20. Forster M. Adjusting household incomes: Equivalence scales. OECD (2005) Available from: URL:http://www.oecd.org/dataoecd/61/52/35411111.pdf
21. Koopmanschap, M.A., Rutten, F.F., van Ineveld, B.M., van Roijen, L.: The friction cost method for measuring indirect costs of disease. J. Health Econ. 14(2), 171-189 (1995)
22. Liljas, B.: How to calculate indirect costs in economic evaluations. Pharmacoeconomics 13(1 Pt 1), 1-7 (1998)
23. Bonneux, L., Birnie, E.: The discount rate in the economic evaluation of prevention: A thought experiment. J. Epidemiol. Community Health 55(2), 123-125 (2001)